Pratap Khedkar and Ganesh Vedarajan co-wrote this blog post with Jess Jarvis.
The COVID-19 pandemic is bringing a lot of uncertainty and turmoil to the life sciences industry, and more broadly across the healthcare ecosystem. But it also has inspired new ways of thinking, collaborating and operating a business—all at a pace that we’ve never quite seen before. To understand the key challenges that manufacturers currently are facing, we invited 14 senior industry leaders to participate in a virtual roundtable, the first in ZS’s Determining the Way Forward After COVID-19 series. One simple question was at the core of every topic we discussed: How can we do what’s best for the patient?